Artwork
iconShare
 
Manage episode 523474760 series 2656045
Content provided by Digital Niche Agency. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Digital Niche Agency or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode of Test, Optimize, and Scale, host Jason Fishman interviews Alan Collier, CEO of SofPulse and Innovo Therapeutics, to discuss pain management, the opioid crisis, and a non-invasive medical device aiming to change how recovery is approached.

SofPulse is an FDA-cleared device designed to reduce post-operative pain and inflammation using pulsed electromagnetic field (PEMF) technology. Alan shares insights into how the device is being explored across different medical settings and what the company is working toward as part of its mission to provide alternatives in post-op care.

Topics covered:

Alan's background in investment banking and medical tech A look at the opioid epidemic's economic and human toll Overview of SofPulse's PEMF technology How the device is being used in post-op recovery Ongoing studies and real-world examples from patients and doctors The role of clinical trials and data in shaping next steps Details on the company's current Wefunder campaign

👉 Learn more: https://wefunder.com/sofpulse 🔗 Connect with Alan Collier on LinkedIn: https://www.linkedin.com/in/collieralan/

  continue reading

213 episodes